We are live on ! Find out more
BSX icon

Boston Scientific

1,708 hedge funds and large institutions have $131B invested in Boston Scientific in 2025 Q3 according to their latest regulatory filings, with 179 funds opening new positions, 767 increasing their positions, 554 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 767 | Existing positions reduced: 554

36% more first-time investments, than exits

New positions opened: 179 | Existing positions closed: 132

14% more call options, than puts

Call options by funds: $1.13B | Put options by funds: $989M

1% more funds holding

Funds holding: 1,6871,708 (+21)

0.86% less ownership

Funds ownership: 91.53%90.67% (-0.86%)

7% less funds holding in top 10

Funds holding in top 10: 4239 (-3)

10% less capital invested

Capital invested by funds: $145B → $131B (-$14.2B)

Holders
1,708
Holders Change
+21
Holders Change %
+1.24%
% of All Funds
22.41%
Holding in Top 10
39
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-7.14%
% of All Funds
0.51%
New
179
Increased
767
Reduced
554
Closed
132
Calls
$1.13B
Puts
$989M
Net Calls
+$140M
Net Calls Change
-$85.7M
Name Holding Trade Value Shares
Change
Change in
Stake
BIG
676
Brooklyn Investment Group
New York
$2.58M -$38.5K -372 -2%
CAG
677
Crestwood Advisors Group
Massachusetts
$2.57M -$5.6M -54,095 -67%
BC
678
Bridgefront Capital
Texas
$2.57M +$1.29M +12,471 +90%
PAS
679
Parsonex Advisory Services
Colorado
$2.56M +$623K +6,012 +30%
VU
680
Vanderbilt University
Tennessee
$2.55M +$1.28M +12,385 +90%
FFN
681
Focus Financial Network
Minnesota
$2.54M +$1.03M +9,952 +62%
GSC
682
G&S Capital
Colorado
$2.54M +$63.3K +611 +2%
NCM
683
Nelson Capital Management
California
$2.53M +$2.68M +25,924 New
SIA
684
Schear Investment Advisers
Ohio
$2.52M +$24.1K +233 +0.9%
FCM
685
Fairbanks Capital Management
California
$2.51M +$2.17K +21 +0.1%
MC
686
Moors & Cabot
Massachusetts
$2.51M -$58.9K -569 -2%
GWMR
687
GC Wealth Management RIA
Massachusetts
$2.5M +$1.12M +10,803 +73%
CP
688
CenterBook Partners
Connecticut
$2.49M +$591K +5,708 +29%
PMWMG
689
Parr McKnight Wealth Management Group
Minnesota
$2.48M +$101K +979 +4%
AWM
690
Apollon Wealth Management
South Carolina
$2.46M +$35.8K +346 +1%
WWM
691
Western Wealth Management
Colorado
$2.43M +$136K +1,309 +6%
BCI
692
Blue Capital Inc
Nebraska
$2.42M +$337K +3,257 +15%
TCM
693
Traynor Capital Management
Pennsylvania
$2.41M +$2.56M +24,724 New
PWM
694
Palumbo Wealth Management
New York
$2.4M +$2.62M +25,330 New
GC
695
Grimes & Company
Massachusetts
$2.38M +$1.65M +15,947 +188%
SF
696
Synovus Financial
Georgia
$2.38M +$53.9K +520 +2%
KWM
697
Kingsman Wealth Management
Florida
$2.37M -$947K -9,142 -27%
SA
698
Strategic Advocates
Utah
$2.35M +$279K +2,697 +13%
DTL
699
Dynamic Technology Lab
Singapore
$2.35M +$2.5M +24,096 New
OF
700
Outfitter Financial
Maine
$2.34M -$20.7K -200 -0.8%

BSX Hedge Fund Activity: Q3 2025 in Review

1,708 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2025, worth a combined $131B — down 9.8% from $145B a quarter earlier.

Buyers outnumbered sellers: 179 funds opened new BSX positions and 132 closed out — a net gain of 47 holders — while 767 added to existing stakes and 554 trimmed.

The largest buyer was Parnassus Investments, adding an estimated $711M. The largest seller was Wellington Management Group, cutting an estimated $1.86B.

  • 1,708 institutional investors held Boston Scientific (BSX) as of Q3 2025, up from 1,687 in Q2 2025.
  • Funds reported $131B of Boston Scientific stock for Q3 2025, down 9.8% quarter-over-quarter.
  • 179 funds opened new Boston Scientific positions in Q3 2025 and 132 closed out, a net change of +47 holders.
  • The largest Boston Scientific buyer in Q3 2025 was Parnassus Investments, an estimated $711M added.
  • The largest Boston Scientific seller in Q3 2025 was Wellington Management Group, an estimated $1.86B sold.

Based on aggregated 13F filings for Q3 2025.